RECENT NEWS

Software to reduce variability in ELISA biomarker tests

Software to reduce variability in ELISA biomarker tests

A new computational approach has been developed to reduce variability in common research biomarker tests, a promising step in improving the ability of biomedical researchers and basic scientists to reproduce data and facilitate more consistent results across laboratories and long-term projects. Researchers from Boston Medical Center (BMC) and Boston University School of Medicine (BUSM), developed a new software program, ELISAtools, which provides a stable platform to
Self-service quantitative PCR calibration

Self-service quantitative PCR calibration

CYCLERtest has introduced self-service calibration tools and support. Even small variations in the performance of qualitative polymerase chain reaction (qPCR) cyclers can damage their operation and reputation; therefore, it is a necessity to calibrate cyclers regularly.
Flexibility and connectivity: a diverse portfolio of products

Flexibility and connectivity: a diverse portfolio of products

Sysmex continues to move from strength to strength in the fields of haemostasis and haematology, not forgetting urinalysis and histopathology, offering robust service delivery, reliability, advanced clinical and scientific parameters, efficient automation solutions and intelligent data management solutions.
Cherwell Laboratories introduces new microbiology product specialist

Cherwell Laboratories introduces new microbiology product specialist

Cherwell Laboratories has appointed Hamish Hogg as Microbiology Product Specialist. This appointment reflects the company’s continued focus on providing high-quality and bespoke cleanroom microbiology products, always supported by excellent customer service.
Walkaway process development with Syrris reactors

Walkaway process development with Syrris reactors

Researchers at TauRx Therapeutics are using the automation capabilities of the Syrris Atlas HD reactor systems to simplify and accelerate process development for its product pipeline. Based at the company’s primary research facilities at the University of Aberdeen, Scotland, the Syrris equipment is an integral part of the quality by design (QBD) process optimisation workflow.
Rapid detection of VTEC and Escherichia coli O157

Rapid detection of VTEC and Escherichia coli O157

Verotoxigenic Escherichia coli (VTEC) or Shiga-toxigenic E. coli are a group of the bacteria that produce a powerful toxin to cause foodborne illness in humans, particularly the serotype E. coli O157 (pictured). It is transmitted via the faecal-oral route when food becomes contaminated with the faeces of infected animals, predominantly cattle.
Scientists’ Choice Award for pipetting robot

Scientists’ Choice Award for pipetting robot

Integra’s innovative ASSIST PLUS pipetting robot has scooped the SelectScience Scientists’ Choice Award for Best New General Laboratory Product of 2018. These prestigious awards highlight the best laboratory technologies to emerge over the last year, and are nominated and voted for by laboratory scientists.
Advancing motor neuron research with single nuclei sequencing

Advancing motor neuron research with single nuclei sequencing

Dolomite Bio’s Nadia instrument is helping researchers to gain a deeper understanding of motor neuron disease through the use of single nuclei RNA sequencing (sNuc-Seq). This automated, microfluidic droplet-based platform allows flexible encapsulation of up to eight samples in parallel in under 20 minutes, helping to accelerate studies and generate high quality data.
Logistical diagnostics: the commercial face of change

Logistical diagnostics: the commercial face of change

The diagnostics market has faced many challenges and changes over the last 30 years and as always those involved in running and continuing the growth of such companies respond to need and change as required. As Mark Reed explains, the in vitro diagnostics (IVD) industry not only faces challenges from continuous scientific progress but also economics, demographics and political unrest.
Micro-platform reveals natural behaviour of cancer cells

Micro-platform reveals natural behaviour of cancer cells

A new cell culture platform allows researchers to observe never-before-seen behaviour of live cancer cells under the microscope, leading to explanations of long-known cancer characteristics.
Specific Gene Mutations predict Success of glioblastoma immunotherapy

Specific Gene Mutations predict Success of glioblastoma immunotherapy

Testing for specific gene mutations may help to predict the patients with glioblastoma who will respond to immunotherapy, according to new research. The findings, published in the journal Nature Medicine also suggest a therapeutic target that could lead to improved immunotherapy in these patients.
Enhancing protein detection and quantification

Enhancing protein detection and quantification

Syngene has introduced a new Epi UV HI-LED lighting option for its popular G:BOX Chemi and G:BOX mini multi-application gel and blot imaging systems. These environmentally friendly lights allow faster workflow and more accurate results when imaging a diverse range of fluorescence-labelled proteins on gels and blots.
Fast and reproducible toxicology testing results

Fast and reproducible toxicology testing results

Synbiosis has introduced its next-generation Ames software module featuring a time-saving Ames mutagenicity ratio calculation function. The new software designed for integrated use with the ProtoCOL 3 colony counter, facilitates rapid production of accurate, consistent count and ratio data from Ames test plates and is ideal for use in regulated toxicology testing laboratories.
Tissue analysis by artificial intelligence

Tissue analysis by artificial intelligence

Nucleai, a promising artificial intelligence (AI) start-up company in the pathology arena is making cancer diagnostics more accurate, accessible and efficient through AI-based analysis of biopsies.
Don Whitley Dies at the Age of 89

Don Whitley Dies at the Age of 89

The directors of Don Whitley Scientific have announced the death, on 28 February after a short illness, of Don Whitley, founder and chairman of the company. Taking a keen interest in the company’s product development projects up until a few weeks before his death, Don would have celebrated his 90th birthday this coming June.
Distorted DNA may increase risk of changes with CRISPR-Cas9

Distorted DNA may increase risk of changes with CRISPR-Cas9

Distortions to DNA, which occur routinely during gene expression and other cellular processes, could lead to off-target changes to the genome when using CRISPR-Cas9, a new study suggests. The Medical Research Council scientists behind the research say that their findings may help to pave the way to improve the accuracy of gene editing for clinical applications.
Fluorescent biosensors as tools for drug therapeutics

Fluorescent biosensors as tools for drug therapeutics

Researchers in the School of Pharmacy at the University of Nottingham have been using Dolomite Microfluidic’s chips to enhance their work on drug encapsulation and therapeutic delivery. Dr Veeren Chauhan, working with Dr Jonathan Aylott and Dr Amjad Selo, explained: “We have been using Dolomite chips since the end of 2017 and have continuously manufactured an array of uniformly-sized PLGA (poly[lactic-co-glycolic acid]) particles. We can fine-tune the system set-up, depending on the downstream requirements, to provide a consistent particle shape and size, as well as control drug release parameters. These attributes are key to ensuring the correct dose of drug is maintained, achieving maximum therapeutic benefit without unwanted side-effects.”
New Cytocell facility to open in Cambridge

New Cytocell facility to open in Cambridge

Oxford Gene Technology (OGT) is expanding its Cytocell operations with a move to a new facility in Cambridge, UK. Cytocell, OGT’s fluorescence in situ hybridisation (FISH) probe brand, will be moving into the significantly larger facility on the prestigious Cambridge Science Park, due to expansion of the organisation, current sales volumes and predicted sales growth. In addition to investing in OGT by expanding Cytocell’s operational footprint, OGT’s parent company, Sysmex, is demonstrating its confidence in the UK by establishing the new premises.
HIV-1 assay receives two CE marks, for viral load and early infant diagnosis

HIV-1 assay receives two CE marks, for viral load and early infant diagnosis

Hologic has announced that its Aptima HIV-1 Quant Dx assay has received two new CE marks in Europe – for early infant diagnosis (EID) and for testing dried blood spots (DBS). This means the assay can be used qualitatively to detect HIV-1 RNA as an aid in the diagnosis of HIV-1-infected infants under 18 months old, and to test an additional sample type (DBS) to monitor viral load and disease progression in HIV-1- infected individuals in European and African countries. It is the first and only dual-claim assay for both viral load and early infant diagnosis.
D-dimer POCT for deep vein thrombosis

D-dimer POCT for deep vein thrombosis

Radiometer’s AQT90 FLEX analysers have been used in a successful trial to asses D-dimer point-of-care testing (POCT) for suspected lower limb deep vein thrombosis (DVT), in which a reduction in patient waiting times of up to 75% was achieved.

Upcoming Events

1st International Blizard/QMUL Tuberculosis Symposium

Bearsted Lecture Theatre, Alexandra Wing, Queen Mary University of London - Whitechapel
26-27 June 2019

HUCBMS 2019

Technological University Dublin
3-4 September 2019

The Oxford Haematology in Obstetrics Postgraduate Course

St Edmund Hall, Queen's Lane, Oxford OX1 4AR
9-11 September 2019

IBMS Biomedical Science Congress

ICC, Birmingham
22-25 September 2019

Lab Innovations

NEC, Birmingham (Hall 12)
30 & 31 October 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Jun 2019

Recent advances in cancer diagnostics

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.